Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 

2021 SC HIV, STD, and Viral Hepatitis Conference (Columbia, SC)


South Carolina HIV, STD and Viral Hepatitis Conference
October 20 & 21, 2021
Columbia Metropolitan Convention Center
1101 Lincoln Street
Columbia, South Carolina 29201
 
 
To register for the conference online, please visit www.midcarolinaahec.org.
To register for the conference via mail, please follow the instructions on the conference website, www.schiv-stdconference.org.
 
The SC HIV, STD and Viral Hepatitis Conference is designed for nurse practitioners, physician assistants, nurses, other clinicians, HIV/STD/Viral Hepatitis educators, social workers, case managers, public health professionals, pharmacists, other service providers, teachers, students, people living with HIV/AIDS and other interested community members. The mission for this interdisciplinary conference is to provide opportunities for professionals and community members to engage in dialogue and share past successes, discuss current practices and interventions, as well as address emerging issues and trends.
 
A total of 6 of the concurrent sessions are ACPE-accredited for pharmacists, and pharmacists may claim a maximum of 6.0 live contact hours (0.6 CEUs) of application and knowledge-based continuing pharmacy education.  
 
To view the schedule of individual sessions as well as their learning objectives, please scroll to the bottom of the page. 
Clicking on the blue bars will expand the session details!

Date: Oct 20, 2021 10:40 AM - Oct 21, 2021 12:50 PM

CE Hours

6.00

CE Units

0.600

Activity Type

  • Knowledge-Based and Application-Based

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Mid-Carolina AHEC

Requirements for CE Credit

Participants must sign in upon arrival and have attendance verified. 
 
To claim credit for this activity, participants must complete the online program evaluation and must update their accounts to properly reflect their month/day of birth and correct NABP e-Profile ID.  To register with NABP or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site. 
 
Credit that is claimed greater than 60 days from the date of the program will be automatically rejected by the CPE Monitor.  Claiming credit within 30 days of the live program will ensure that any issues with transmission to the CPE Monitor can be rectified in advance of the 60-day deadline.  If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-Profile.
 

 

 

 

 

At the completion of this activity, the participant will be able to:
  1. Identify viral suppression trends for people living with HIV (PLWH) using Medicaid
  2. Describe retention in care trends for PLWH using Medicaid
  3. Recognize mortality trends for PLWH using Medicaid

Speaker(s)/Author(s)

Tony Brown, MPH
Prevention Planning and Evaluation Coordinator, STD/HIV & Viral Hepatitis Division, South Carolina DHDC

Activity Number

0062-9999-21-137-L02-P
Date: 10/20/21
Time: 10:40 AM - 11:40 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Review current treatment and prevention guideline recommendations for HIV
  2. Review new medications for HIV
  3. Review top research findings in HIV

Speaker(s)/Author(s)

Sharon Weissman, MD
Clinical Professor of Medicine, University of South Carolina School of Medicine

Activity Number

0062-9999-21-138-L02-P
Date: 10/20/21
Time: 11:50 AM - 12:50 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Discuss the latest Hepatitis C screening and testing recommendations
  2. Review Hepatitis C lab interpretation
  3. Discuss the Hepatitis C Treatment Guidelines including the simplified algorithm

Speaker(s)/Author(s)

Divya Ahuja, MD, MRCP (London)
Associate Professor of Clinical Internal Medicine, Prisma Health -University of South Carolina, School of Medicine (USC SOM); Principal Investigator, South Carolina HIV/AIDS Training Center, USC SOM; Medical Director, Immunology Center, Prisma Health

Activity Number

0062-9999-21-139-L01-P
Date: 10/20/21
Time: 02:40 PM - 03:40 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Explain the importance of HIV PrEP-to-need ratios (PnRs) and the variability in HIV PnRs among counties in South Carolina
  2. Discuss associations identified between HIV PnRs and literacy rates at the county level in South Carolina
  3. Analyze strategies to improve HIV PnRs among underrepresented counties in South Carolina

Speaker(s)/Author(s)

Kenric Ware, PharmD, MBA, AAHIVP
Pharmacist | Board of Directors Chairperson, Joseph H. Neal Health Collaborative

Mia Turner, PharmD Candidate 2022
South University

Activity Number

0062-9999-21-140-L02-P
Date: 10/20/21
Time: 03:50 PM - 04:50 PM

CE Hours

1.00
 

 

 

At the completion of this activity, the participant will be able to:
  1. Apply current recommendations regarding cabotegravir and rilpivirine long-acting injectable for the treatment of HIV
  2. Summarize the efficacy and safety of cabotegravir and rilpivirine long-acting injectable for HIV treatment
  3. Describe the workflow of implementing cabotegravir and rilpivirine long-acting injectable into real-world practice

Speaker(s)/Author(s)

Morgan Pizzuti, PharmD
PGY2 Infectious Diseases Pharmacy Resident, Prisma Health - Richland, University of South Carolina

Y. Vivian Tsai, PharmD
Infectious Diseases Clinical Pharmacy Fellow, Prisma Health Richland - University of South Carolina

Activity Number

0062-9999-21-141-L02-P
Date: 10/21/21
Time: 10:40 AM - 11:40 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Describe emerging treatment options for HIV infected individuals
  2. Apply barriers to use of these agents in clinical practice to a real patient case
  3. Outline prevention strategies on the horizon for HIV

Speaker(s)/Author(s)

Caroline Derrick, PharmD, BCPS, AAHIVP
Infectious Diseases Ambulatory Pharmacy Supervisor, USC School of Medicine, Department of Internal Medicine, Prisma Health-Midlands

Activity Number

0062-9999-21-142-L02-P
Date: 10/21/21
Time: 11:50 AM - 12:50 PM

CE Hours

1.00